PEOPLE - Enpath Medical makes appointment:
This article was originally published in Clinica
Executive Summary
Scott Youngstrom has been named as CFO of percutaneous delivery systems specialist Enpath Medical (Plymouth, Minnesota). He replaces James Hartman, who stepped down in January, but who will continue as chairman of the board of directors. Mr Youngstrom, who has 20 years of financial experience in the medtech industry, joins from Compex Technologies (electronic muscle stimulation devices), where he was president and CFO.
You may also be interested in...
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.